120 related articles for article (PubMed ID: 26104926)
1. What Is Reasonably Foreseeable? Lessons Learned From the SUPPORT Trial.
Trifiletti DM; Showalter TN; Shepherd L
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):718-20. PubMed ID: 26104926
[No Abstract] [Full Text] [Related]
2. Risk, consent, and SUPPORT.
Magnus D; Caplan AL
N Engl J Med; 2013 May; 368(20):1864-5. PubMed ID: 23597408
[No Abstract] [Full Text] [Related]
3. Informed consent and SUPPORT.
Drazen JM; Solomon CG; Greene MF
N Engl J Med; 2013 May; 368(20):1929-31. PubMed ID: 23593944
[No Abstract] [Full Text] [Related]
4. Ethical pitfalls in neonatal comparative effectiveness trials.
Modi N
Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
[TBL] [Abstract][Full Text] [Related]
5. What do we aim for? Oxygen saturation targets in extremely preterm infants.
Fidler HL
Adv Neonatal Care; 2011 Dec; 11(6):404-5. PubMed ID: 22123472
[No Abstract] [Full Text] [Related]
6. Vindication for SUPPORT.
Lantos JD
N Engl J Med; 2015 Oct; 373(15):1393-5. PubMed ID: 26332442
[No Abstract] [Full Text] [Related]
7. Oxygen-saturation targets in extremely preterm infants.
Carlo WA; Bell EF; Walsh MC;
N Engl J Med; 2013 May; 368(20):1949-50. PubMed ID: 23593943
[No Abstract] [Full Text] [Related]
8. Foreseeable risks? Informed consent for studies within the standard of care.
Sacks CA; Warren CE
N Engl J Med; 2015 Jan; 372(4):306-7. PubMed ID: 25517574
[No Abstract] [Full Text] [Related]
9. The US Office for Human Research Protections' judgment of the SUPPORT trial seems entirely reasonable.
Pharoah PD
BMJ; 2013 Jul; 347():f4637. PubMed ID: 23881993
[No Abstract] [Full Text] [Related]
10. Were There "Additional Foreseeable Risks" in the SUPPORT Study? Lessons Not Learned from the ARDSnet Clinical Trials.
Silverman HJ; Dreyfuss D
Hastings Cent Rep; 2015; 45(1):21-9. PubMed ID: 25530226
[TBL] [Abstract][Full Text] [Related]
11. US researchers failed to disclose risks of newborn study, finds government office.
McCarthy M
BMJ; 2013 Apr; 346():f2367. PubMed ID: 23585233
[No Abstract] [Full Text] [Related]
12. Oxygen saturation in immature babies: revisited with updated recommendations.
Saugstad OD; Speer CP; Halliday HL
Neonatology; 2011; 100(3):217-8. PubMed ID: 21757963
[No Abstract] [Full Text] [Related]
13. [Oxygen to premature births--a new scandal?].
Saugstad OD
Tidsskr Nor Laegeforen; 2013 Oct; 133(19):2062-4. PubMed ID: 24129538
[No Abstract] [Full Text] [Related]
14. The US Office for Human Research Protections' intervention in the SUPPORT trial was indeed ill conceived.
Thornton H
BMJ; 2013 Jul; 347():f4639. PubMed ID: 23881994
[No Abstract] [Full Text] [Related]
15. [Oxygen to newborns].
Saugstad OD
Tidsskr Nor Laegeforen; 2011 Dec; 131(24):2488-90. PubMed ID: 22170138
[No Abstract] [Full Text] [Related]
16. SUPPORT and the Ethics of Study Implementation: Lessons for Comparative Effectiveness Research from the Trial of Oxygen Therapy for Premature Babies.
Lantos JD; Feudtner C
Hastings Cent Rep; 2015; 45(1):30-40. PubMed ID: 25530316
[TBL] [Abstract][Full Text] [Related]
17. An Ethical Analysis of the SUPPORT Trial: Addressing Challenges Posed by a Pragmatic Comparative Effectiveness Randomized Controlled Trial.
Horn AR; Weijer C; Grimshaw J; Brehaut J; Fergusson D; Goldstein CE; Taljaard M
Kennedy Inst Ethics J; 2018; 28(1):85-118. PubMed ID: 29628452
[TBL] [Abstract][Full Text] [Related]
18. [When the information provided to participants of a comparative effectiveness trial ends up in the court: The opening of Pandora's box?].
Dal-Ré R; Omeñaca F; Gracia D
Med Clin (Barc); 2016 Jul; 147(2):76-80. PubMed ID: 26961391
[No Abstract] [Full Text] [Related]
19. Giving small babies oxygen: 50 years of uncertainty.
Tin W; Wariyar U
Semin Neonatol; 2002 Oct; 7(5):361-7. PubMed ID: 12464498
[TBL] [Abstract][Full Text] [Related]
20. Informed consent and standard of care: what must be disclosed.
Macklin R; Shepherd L
Am J Bioeth; 2013; 13(12):9-13. PubMed ID: 24256523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
